Austin Angelo

About the Author Austin Angelo


Why Did Cantor Fitzgerald Downgrade Aquinox Pharmaceuticals’ Stock?

Aquinox Pharmaceuticals (NASDAQ: AQXP) received a Hold rating and a $2 price target from Cantor Fitzgerald analyst William Tanner today. The company’s shares …

Medicines Co Gets a Buy Rating from Chardan Capital

Chardan Capital analyst Gbola Amusa maintained a Buy rating on Medicines Co (NASDAQ: MDCO) today and set a price target of $85. The …

Atricure Gets a Hold Rating from BTIG

BTIG analyst Sean Lavin maintained a Hold rating on Atricure (NASDAQ: ATRC) yesterday. The company’s shares closed yesterday at $27.

Analysts Offer Insights on Technology Companies: Splunk Inc (SPLK), Veeva Systems (VEEV) and Appian Corp (APPN)

Analysts have been eager to weigh in on the Technology sector with new ratings on Splunk Inc (NASDAQ: SPLK), Veeva Systems (NYSE: VEEV) …

Arch Therapeutics Inc Receives a Buy from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C.

Pivotal Research Sticks to Its Hold Rating for Time Warner Inc

Pivotal Research analyst Brian Wieser maintained a Hold rating on Time Warner Inc (NYSE: TWX) yesterday. The company’s shares closed last Thursday at …

Cantor Fitzgerald Reaffirms Their Buy Rating on Apellis Pharmaceuticals Inc

In a report released yesterday, Elemer Piros from Cantor Fitzgerald reiterated a Buy rating on Apellis Pharmaceuticals Inc (NASDAQ: APLS), with a price …

Mizuho Securities Reaffirms Their Buy Rating on Autoliv

Mizuho Securities analyst Vijay Rakesh reiterated a Buy rating on Autoliv (NYSE: ALV) yesterday and set a price target of $160. The company’s …

Cantor Fitzgerald Reaffirms Their Buy Rating on Aldeyra Therapeutics

Cantor Fitzgerald analyst Elemer Piros reiterated a Buy rating on Aldeyra Therapeutics (NASDAQ: ALDX) today and set a price target of $23. The …

Dana Holding Gets a Hold Rating from B.Riley FBR

B.Riley FBR analyst Christopher Van Horn reiterated a Hold rating on Dana Holding (NYSE: DAN) yesterday and set a price target of $25.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts